The UCT Clinical Trials Unit, housed within the Desmond Tutu HIV Centre (DTHC) at the University of Cape Town, is committed to the pursuit of excellence in research, treatment, training and prevention of HIV and related infections in Southern Africa
In 2013 the Desmond Tutu HIV Foundation partnered with the Faculty of Health Sciences, Departments of Medicine and Pharmacology at the University of Cape Town to establish an expanded Clinical Trials Unit.
Our CTU model regards training and development as an important function. We invest in our staff through a robust and agile training program that positively impacts performance of our study teams.
Home > Home


Saturday, 22 January 2022
NIH Launches New Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global Scale

Initial investment aims to advance accessible and scalable candidate interventions into clinical trials within 10 years.

Publication Date:
Fri, 22 Nov 2019 - 09:45
Ready, Set, PrEP Expands Access to Medication to Prevent HIV

The U.S. Department of Health and Human Services (HHS) today launched Ready, Set, PrEP, a national program that makes medications for pre-exposure prophylaxis (PrEP), taken daily to prevent HIV, available at no cost to people without prescription drug insurance coverage.

Publication Date:
Wed, 04 Dec 2019 - 14:30
Guidelines fail to address needs of adolescents living with HIV transitioning to adult health care in low- and middle-income countries

Only five of 12 low- and middle-income countries had transition guidelines, according to a systemic review of adolescents living with HIV transitioning from paediatric to adult health care published in AIDS and Behavior.

The authors believe this to be the first review to survey the literature on barriers and facilitators of transition for adolescents living with HIV in low- and middle-income countries and to compare these factors to countries’ current guidelines.

Publication Date:
Fri, 11 Oct 2019 - 22:00
Same day treatment IAS
Same-day initiation of ART feasible and safe without CD4 counts, Thai study shows

Three models of same-day antiretroviral therapy (ART), tested in different hospitals in Thailand, are feasible and safe, researchers report. The models have been implemented in Thailand since 2017, following a World Health Organization recommendation that all individuals diagnosed as HIV positive should receive ART on the same day of diagnosis, if they are ready.

Publication Date:
Fri, 11 Oct 2019 - 21:45